International Cannabis Weekly: 442

RESCHEDULING STALEMATE LEAVES MSOS FACING A BILLION DOLLAR TAX RECKONING

The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now presenting some real-world issues for many of the sector’s largest players.

READ MORE  »

GERMANY’S MEDICAL CANNABIS PRODUCT RANGE QUADRUPLES AS PRICES FALL 30%

READ MORE »

BEYOND THE ABSTRACT: WHAT THE LANDMARK LANCET PSYCHIATRY REVIEW SHOWS

READ MORE »

UK hemp industry has all necessary fundamentals but remains constrained by current legal framework.

German cannabis market expansion shows signs of slowing or entering a phase of normalisation.

German medical cannabis market records surge with more than 200 tonnes imported in 2025.

Industrial hemp leaders from around the world to gather in Poland for 23rd EIHA conference.

Cannacare has been removed from Infarmed list of licensed cannabis companies in Portugal.

Tilray Medical, CC Pharma and 14U Pharma form strategic alliance with Gesund Leben healthcare network.

Diverging cannabis usage trends highlight uneven impact of Europe’s policy landscape.

APPLY TO EXHIBIT »

Cresco Labs stock faces headwinds as consolidation reshapes US cannabis market.

DEA educational materials acknowledge declining youth cannabis use as legalisation expands.

Colorado legislative committee rejects proposal to place cannabis and alcohol tax increases on November ballot.

Congressional researchers provide update on cannabis rescheduling and potential hemp THC restrictions.

Innovative Industrial Properties maintains $1.90 quarterly dividend amid stable performance.

Georgia House passes bill aimed at expanding access to state medical cannabis programme.

Perrysburg considers long-term decision on allowing cannabis-related businesses within city limits.

Cannabis Teamsters in Chicago have ratified a brand new labour contract agreement.

Legacy cannabis brand announces nationwide expansion of product offerings across US markets.

Virginia lawmakers pass measures to legalise recreational cannabis sales.

Avant Brands announces strategic realignment of operations and reclaims brand rights in Germany and Switzerland.

Canadian cannabis exports balance rising global demand with domestic branding challenges.

Canopy Growth completes acquisition of MTL Cannabis to form leading medical cannabis business in Canada.

Tilray shares struggle despite strategic BrewDog deal and broader market pressures.

Village Farms reports strong fourth-quarter results with revenue growth and increased cannabis sales.

Canadian cannabis industry coverage highlights evolving market dynamics and regulatory environment.

Canadian cannabis producers increasingly look to international markets as US industry growth stalls.

Federal Court overturns Health Canada decision to deny cannabis security clearance.

Chile faces pivotal moment as potential hard-right presidency raises questions for cannabis policy future.

Quality of cannabis products produced by Brazil’s industry comes under increasing scrutiny.

Comodoro advances local agenda focused on medical, scientific and productive cannabis development.

Uruguay’s cannabis exports surpass $25 million in 2025 as international demand grows.

The People’s Plant nears $1.5 million target as crowdfunding offer approaches close.

Australian cannabis has exported to Germany triple as total imports exceed 200 tonnes.

Vitura Health signs online distribution agreement for MedReleaf medicinal cannabis products

Stock shortages, insolvencies and redundancies expose ‘growing pains’ in NZ market.

Cannabis compounds CBD and CBG show potential in treating fatty liver disease.

Ghana has moved forward with legalisation of medical and industrial cannabis sectors